Last updated on July 2020

Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Severe Asthma
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria

Patients must fulfil all of the following inclusion criteria to be included in the study:

  • Male or female patient, aged 12 years or older by the time of study entry
  • Patient visiting a participating center for a routine clinical appointment
  • Patient is willing and able to provide a blood sample for IgE and eosinophil levels determination as part of their routine clinical visit
  • Diagnosis of severe asthma for at least one year as defined by:
  • Treatment with guidelines-suggested medications for Global Initiative for Asthma (3) steps 4-5 asthma
  • Patients or their legal guardian, who voluntarily sign and date the informed consent form prior to study entry.

Exclusion Criteria

  • Patients with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory condition beyond severe asthma
  • An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study Patients who are currently under a biologic therapy to treat their severe asthma

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.